Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_assertion type Assertion NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_head.
- NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_assertion description "[Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_provenance.
- NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_assertion evidence source_evidence_literature NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_provenance.
- NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_assertion SIO_000772 19530242 NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_provenance.
- NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_assertion wasDerivedFrom befree-20150227 NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_provenance.
- NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_assertion wasGeneratedBy ECO_0000203 NP486157.RAVaKg-NU5dENbVNqEeRNZzIdjsELRrqJJSs_weZMxRYE130_provenance.